BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24127404)

  • 21. Poor vessel formation in embryos from knock-in mice expressing ALK5 with L45 loop mutation defective in Smad activation.
    Itoh F; Itoh S; Carvalho RL; Adachi T; Ema M; Goumans MJ; Larsson J; Karlsson S; Takahashi S; Mummery CL; Dijke PT; Kato M
    Lab Invest; 2009 Jul; 89(7):800-10. PubMed ID: 19398960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.
    Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A
    J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
    Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
    J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.
    Itoh S; Thorikay M; Kowanetz M; Moustakas A; Itoh F; Heldin CH; ten Dijke P
    J Biol Chem; 2003 Feb; 278(6):3751-61. PubMed ID: 12446693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ALK5 and ALK1 play antagonistic roles in transforming growth factor β-induced podosome formation in aortic endothelial cells.
    Curado F; Spuul P; Egaña I; Rottiers P; Daubon T; Veillat V; Duhamel P; Leclercq A; Gontier E; Génot E
    Mol Cell Biol; 2014 Dec; 34(24):4389-403. PubMed ID: 25266657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-β receptor maintains CD4 T helper cell identity during chronic viral infections.
    Lewis GM; Wehrens EJ; Labarta-Bajo L; Streeck H; Zuniga EI
    J Clin Invest; 2016 Oct; 126(10):3799-3813. PubMed ID: 27599295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma.
    Fukasawa H; Yamamoto T; Fujigaki Y; Misaki T; Ohashi N; Takayama T; Suzuki S; Mugiya S; Oda T; Uchida C; Kitagawa K; Hattori T; Hayashi H; Ozono S; Kitagawa M; Hishida A
    Int J Cancer; 2010 Oct; 127(7):1517-25. PubMed ID: 20073064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
    Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
    Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of TGF-β receptor-1 as a key regulator of carbon nanotube-induced fibrogenesis.
    Mishra A; Stueckle TA; Mercer RR; Derk R; Rojanasakul Y; Castranova V; Wang L
    Am J Physiol Lung Cell Mol Physiol; 2015 Oct; 309(8):L821-33. PubMed ID: 26472812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta type 1 receptor (ALK5) and Smad proteins mediate TIMP-1 and collagen synthesis in experimental intestinal fibrosis.
    Medina C; Santos-Martinez MJ; Santana A; Paz-Cabrera MC; Johnston MJ; Mourelle M; Salas A; Guarner F
    J Pathol; 2011 Aug; 224(4):461-72. PubMed ID: 21465486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VprBP mitigates TGF-β and Activin signaling by promoting Smurf1-mediated type I receptor degradation.
    Li Y; Cui C; Xie F; Kiełbasa S; Mei H; van Dinther M; van Dam H; Bauer A; Zhang L; Ten Dijke P
    J Mol Cell Biol; 2020 Feb; 12(2):138-151. PubMed ID: 31291647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands.
    Cortez VS; Cervantes-Barragan L; Robinette ML; Bando JK; Wang Y; Geiger TL; Gilfillan S; Fuchs A; Vivier E; Sun JC; Cella M; Colonna M
    Immunity; 2016 May; 44(5):1127-39. PubMed ID: 27156386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative control of TRAIL-R1 signaling by transforming growth factor β1 in pancreatic tumor cells involves Smad-dependent down regulation of TRAIL-R1.
    Radke DI; Ungefroren H; Helm O; Voigt S; Alp G; Braun H; Hübner S; Dilchert J; Sebens S; Adam D; Kalthoff H; Trauzold A
    Cell Signal; 2016 Nov; 28(11):1652-62. PubMed ID: 27492861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concordant repression and aberrant methylation of transforming growth factor-beta signaling pathway genes occurs early in gastric cardia adenocarcinoma.
    Guo W; Dong Z; Guo Y; Kuang G; Yang Z; Shan B
    Mol Biol Rep; 2012 Oct; 39(10):9453-62. PubMed ID: 22722999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The oncoprotein c-ski functions as a direct antagonist of the transforming growth factor-{beta} type I receptor.
    Ferrand N; Atfi A; Prunier C
    Cancer Res; 2010 Nov; 70(21):8457-66. PubMed ID: 20959473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A critical role for transcription factor Smad4 in T cell function that is independent of transforming growth factor β receptor signaling.
    Gu AD; Zhang S; Wang Y; Xiong H; Curtis TA; Wan YY
    Immunity; 2015 Jan; 42(1):68-79. PubMed ID: 25577439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.